Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114044751A discloses a scalable synthesis of PhthSCF2D. This stable reagent enables high-purity deuteration in drug molecules, offering significant supply chain advantages.
Novel carbonylation route for 4,4-dimethylisoxazol-3-one. High purity, green process for clomazone production. Cost-effective supply chain solution.
Patent CN1332944C details a mild CuI-catalyzed coupling method using amino acids, offering a cost-effective and scalable route for high-purity pharmaceutical intermediates and fine chemicals.
High-yield synthesis of 7-methoxycoumarin-3-carboxylic acid via novel cyclization. Reduces costs and ensures supply chain stability for pharma intermediates.
Patent CN109553557B reveals a safe, metal-free route to thiosulfonates using DABSO. Ideal for reliable pharmaceutical intermediates supplier seeking cost-effective scaling.
Patent CN113862710B reveals metal-free electrochemical route. Offers green manufacturing and supply chain reliability for high-purity intermediates.
Patent CN102209723A reveals a solvent-free method for high-purity 6-chlorodibenzo dioxaphosphepin. Discover cost-effective scaling and supply chain advantages for ligand synthesis.
Patent CN109096211B reveals a low-temperature acid-catalyzed route for polysubstituted triazoles, offering high purity and simplified supply chains for pharmaceutical intermediates.
Discover efficient organocatalytic synthesis of oxazolin-2-one derivatives. High stereoselectivity and mild conditions for reliable agrochemical intermediate supply.
Patent CN114315760A details a sulfuric acid-assisted chlorination method for 2-chloro-1-(4-morpholinylphenyl)-1-butanone, offering superior selectivity and cost efficiency for photoinitiator manufacturing.
Novel pH-controlled purification enhances purity and reduces waste for reliable 8-hydroxyquinoline supply chains. This technical insight supports cost reduction in pharmaceutical intermediate manufacturing and ensures high-purity material availability.
Discover a novel preparation method for N-phenyl bis(trifluoromethanesulfonyl) imide using trifluoromethanesulfonyl fluoride. Achieve high purity and significant cost reduction.
Novel sulfur reduction process for high-purity 3-chloro-2-methylaniline. Cost-effective herbicide intermediate manufacturing with simplified workup.
Patent CN114605306A reveals a novel nickel-catalyzed method using alkyl xanthates for odorless, high-yield organosulfur synthesis, offering significant cost and supply chain advantages.
Novel aziridine ring-opening route eliminates toxic reductants, offering a safer, scalable supply chain for cardiovascular drug intermediates.
Patent CN106349295B reveals mild reduction method. Offers cost reduction in pharma intermediate manufacturing and high-purity aniline derivatives.
Patent CN109232372A reveals a novel carbonylation route for high-purity isoindoline dione synthesis, offering significant supply chain stability and cost reduction advantages.
Patent CN109336825A reveals stabilized mother liquor recycling for 5-ABI. High purity pigment intermediate. Significant cost reduction and supply reliability.
Patent CN107365273B reveals one-pot method improving yield and reducing waste for high-purity pharmaceutical intermediate manufacturing.
Patent CN114315528A reveals a mild silver-catalyzed route for 4-diarylmethyl phenols, offering high regioselectivity and cost reduction in pharmaceutical intermediate manufacturing.